业务
货币单位:日元
2024/FY
名称营收比例
Regenerative medical products business14.07亿55.95%
Regenerative medicine contract business8.66亿34.43%
Research and development support project2.42亿9.63%
地区
货币单位:日元
2024/FY
名称营收比例
日本22.63亿90.00%
其他2.51亿10.00%
